VANDA PHARMACEUTICALS INC. (VNDA) Shareholders’ equity 2016–2025
VANDA PHARMACEUTICALS INC. (VNDA) shareholders’ equity at each fiscal year-end, per SEC filings.
$327.2MFY2025 · since FY2016: $131.3M → $327.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $327.2M | -39.2% |
| FY2024 | $538.5M | -1.2% |
| FY2023 | $544.9M | +3.4% |
| FY2022 | $527.2M | +4.4% |
| FY2021 | $504.9M | +11.4% |
| FY2020 | $453.3M | +10.3% |
| FY2019 | $410.9M | +49.2% |
| FY2018 | $275.4M | +109.6% |
| FY2017 | $131.4M | +0.0% |
| FY2016 | $131.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice